Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma

Cells lacking the tumor suppressor gene alter their metabolism to match the demands of accelerated growth, leaving them highly vulnerable to stress. However, targeted therapy for LKB1-deficient cancers has yet to be reported. In both cell lines and a genetically engineered mouse model of -induced lu...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 77; no. 18; pp. 5068 - 5076
Main Authors Liu, Yan, Li, Yuyang, Wang, Xiaoen, Liu, Feiyang, Gao, Peng, Quinn, Max M, Li, Fei, Merlino, Ashley A, Benes, Cyril, Liu, Qingsong, Gray, Nathanael S, Wong, Kwok-Kin
Format Journal Article
LanguageEnglish
Published United States American Association for Cancer Research, Inc 15.09.2017
Subjects
Online AccessGet full text

Cover

Loading…